RxDoctor Payments Data

Christopher Ross, MD

Radiation Oncology · Little Rock, ARNPI 1922288372

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Visionrt, Inc. accounts for 72.1% of it on its own, with 3 other manufacturers making up the rest. That places this record below the midpoint for radiation oncology clinicians in AR, where the typical reported total is $819.

$146in general payments, 2019–2025

Across 4 payments — averaging $36.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Visionrt, Inc.$105
  • Siemens Medical Solutions USA, Inc.$15
  • Varian Medical Systems, Inc.$13
  • AbbVie$13

What the payments were for

  • Food & beverage$146100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Visionrt, Inc.1$105
Siemens Medical Solutions USA, Inc.1$15
Varian Medical Systems, Inc.1$13
AbbVie1$13

How this compares

$146 in reported general payments places this provider in the 20th percentile of 45 radiation oncology providers in Arkansas.

See all radiation oncology providers in Arkansas

Medicare billing

Part B allowed, 2024
$401,746
Medicare patients
221
Services billed
5,339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone17$422
Tamsulosin Hcl16$273
Mometasone Furoate11$243

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →